COMMUNIQUÉS West-GlobeNewswire

Inventiva réalise une augmentation de capital de 8,2 millions d'euros souscrite par des investisseurs américains et européens de premier plan dans le secteur des biotechnologies
19/09/2019
Un nouveau financement permettant à la Société d'étendre sa visibilité financière du 2 ème trimestre 2020 jusqu'à la fin du 3 ème trimestre 2020 au-delà des résultats des études cliniques en cours sur lanifibranor et [...]
Annual Financial Report
19/09/2019
DXS INTERNATIONAL PLC ANNUAL RESULTS for the year ended 30 April 2019 The Board of DXS International plc (“the Company”), the NEX Growth Market quoted healthcare information and digital clinical decision support systems [...]
Verona Pharma to Present Phase 2 Data with Ensifentrine Dry Powder Inhaler Formulation in COPD at European Respiratory Society International Congress 2019
19/09/2019
LONDON, Sept. 19, 2019 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a biopharmaceutical company focused on respiratory diseases, announces that it will present positive interim data [...]
Sequana Medical Appoints Leading Experts as Heart Failure Scientific Advisors
19/09/2019
Dr. Butler, Dr. Costanzo, Dr. Tang and Dr. Testani to advise on alfa pump® DSR development GHENT, Belgium, Sept. 19, 2019 (GLOBE NEWSWIRE) -- Sequana Medical NV (Euronext Brussels: SEQUA) , innovators in the management [...]
Roche renews its commitment to the primary healthcare Phelophepa trains, marking the 25th anniversary
19/09/2019
Roche and Transnet, the main freight logistics company in South Africa, came together in 1994 to establish Phelophepa, the world’s first comprehensive primary healthcare facility on rail Phelophepa has touched the lives [...]
Roche renouvelle son engagement en faveur des trains médicaux Phelophepa, marquant leur 25e anniversaire
19/09/2019
Roche et Transnet, principale entreprise sud-africaine de logistique de fret, se sont associées en 1994 pour créer Phelophepa, premier établissement de soins de santé primaires complets sur rails au monde Depuis son [...]
PRA Health Sciences et Symphony Health lancent l'outil de mesure du marché national Metys(TM)
19/09/2019
Metys(TM) est le premier en son genre à fournir rapidement des données précises et fiables via un point d'accès unique RALEIGH, N.C., 19 sept. 2019 (GLOBE NEWSWIRE) -- PRA Health Sciences (NASDAQ : PRAH) a annoncé [...]
Progenics Confirms Notice of Preliminary Consent Solicitation by Velan Capital, L.P. Despite Repeated Efforts by the Company to Reach a Reasonable Resolution
18/09/2019
Board Has Made Numerous Corporate Governance Enhancements Reflecting Feedback From Shareholders No Shareholder Action Required at this Time NEW YORK, Sept. 18, 2019 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. ( [...]
Nxt-ID, Inc. names Vincent S. Miceli as new Chief Executive Officer
18/09/2019
SEBASTIAN, Florida, Sept. 18, 2019 (GLOBE NEWSWIRE) -- Nxt-ID, Inc. (NASDAQ: NXTD) (the “Company”), a provider of healthcare devices and services, announced today that Gino M. Pereira has resigned from his roles as [...]
Integra LifeSciences Presents Cadence® Total Ankle System Retrospective Study Abstract at AOFAS
18/09/2019
PLAINSBORO, N.J., Sept. 18, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company, today announced positive findings from its Cadence® Total Ankle [...]
AGTC to Host Fourth Quarter and Fiscal Year Financial Results Conference Call and Webcast on September 26, 2019
18/09/2019
GAINESVILLE, Fla., and CAMBRIDGE, Mass., Sept. 18, 2019 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus ( [...]
Oasmia publishes report on special investigation of liability issues conducted by audit firm Deloitte
18/09/2019
In connection with Oasmia's year-end report in June 2019, the company's Board of Directors made a decision to engage a special examiner, audit firm Deloitte (Svante Forsberg responsible investigator), to investigate the [...]
Oasmia presents Q1 report through audiocast on September 26
18/09/2019
Oasmia will hold an audiocast and telephone conference on Thursday 26 September at 10:00 (CET) to present the company's Q1 report for the financial year 2019/2020. The presentation of the Q1 report will be in English. [...]
Dr. Emilio Canal, Jr., D.D.S., F.A.S.D. has been elected as President of the Professional Soccer Dental Society
18/09/2019
RESTON, Va., Sept. 18, 2019 (GLOBE NEWSWIRE) -- The Dental Group at Reston Station is pleased to announce that Dr. Emilio Canal, Jr., D.D.S., F.A.S.D. has been elected as President of the Professional Soccer Dental [...]
The efficacy of Hebelys® once again demonstrated and promoted in the International Journal of Cosmetic Science
18/09/2019
The efficacy of Hebelys® once again demonstrated and promoted in the International Journal of Cosmetic Science New in vitro and clinical efficacy data have been published; Sphingomonas hydrophobicum extract, the active [...]
L’efficacité d’Hebelys® à nouveau démontrée et promue dans l’International Journal of Cosmetic Science
18/09/2019
L’efficacité d’Hebelys® à nouveau démontrée et promue dans l’ International Journal of Cosmetic Science De nouvelles données d’efficacité in vitro et cliniques ont été publiées ; L'extrait de Sphingomonas hydrophobicum [...]
OSE Immunotherapeutics Receives a Milestone Payment of €5.4 Million From Bpifrance for SIRPα-Antagonist Monoclonal Antibody BI 765063
18/09/2019
First-in-Class Myeloid Checkpoint Inhibitor BI 765063* is Currently in Phase 1 Clinical Development in Advanced Solid Tumors in Partnership with Boehringer Ingelheim Milestone Endorses OSE’s Business Model and Marks [...]
Okaloosa County Jail Renews Partnership With Corizon Health
18/09/2019
BRENTWOOD, Tenn., Sept. 18, 2019 (GLOBE NEWSWIRE) -- The Department of Corrections in Okaloosa County, Florida, has renewed its contract for medical services with Corizon Health for an additional term, the company [...]
Thymidine Kinase 1 can be used for early detection of therapy response in breast cancer treatment
18/09/2019
Patients treated with Epirubicin and Docetaxel before surgery were followed by their thymidine kinase (TK1) levels in blood to directly observe treatment response. The results show that a TK1-based cell-loss metric [...]

Pages